Cannabis Control Commission Public Meeting
In accordance with Sections 18-25 of Chapter 30A of the Massachusetts General Laws, notice is hereby given of a meeting of the Cannabis Control Commission. The meeting will take place as noted below.
July 17, 2019
1:00PM
Location:
Massachusetts Gaming Commission
101 Federal Street, 12th Floor
Boston, MA 02110
Public Meeting Agenda:
1) Call to Order
2) Chairman’s Comments & Updates
3) Minutes from June 13, 2019
4) Executive Director’s Report
a. Social Equity Program Vendor Selection
b. Job Description, Project Coordinator
c. Renewal Process
5) Staff Recommendations on Renewals
a. Cultivate Holdings, LLC (#MCR139823), Cultivation Renewal
b. Cultivate Holdings, LLC (#MRR205524), Retail Renewal
c. Alternative Therapies Group, Inc. (#MCR139822), Cultivation Renewal
d. Alternative Therapies Group, Inc. (#MPR243478), Product Manufacturing Renewal
e. Alternative Therapies Group, Inc. (#MRR205522), Retail Renewal
f. SIRA Natural, Inc., (#MCR139821), Cultivation Renewal
g. SIRA Natural, Inc., (#MXR126654), Third Party Transporter Renewal
h. SIRA Natural, Inc., (#MPR243480), Product Manufacturing Renewal
i. New England Treatment Access, LLC (#MCR139825), Cultivation Renewal
j. New England Treatment Access, LLC (#MRR205525), Retail Renewal
k. New England Treatment Access, LLC (#MRR205526), Retail Renewal
l. New England Treatment Access, LLC (#MRR205523), Retail Renewal
m. Pharmacannis Massachusetts, Inc. (#MPR243479), Product Manufacturing
n. Bewell Organic Medicine, Inc. (#RMD1245), Vertically Integrated Medical Marijuana Treatment Center
o. INSA, Inc. (#RMD845), Vertically Integrated Medical Marijuana Treatment Center
p. Ipswich Pharmaceutical Associates, Inc., Vertically Integrated Medical Marijuana Treatment Center
q. Mayflower Medicinals, Inc. (#RMD425), Vertically Integrated Medical Marijuana Treatment Center
r. Mayflower Medicinals, Inc., Vertically Integrated Medical Marijuana Treatment Center
s. Wellness Connection of Ma, Inc., Vertically Integrated Medical Marijuana Treatment Center
t. Sanctuary Medicinals, Inc. (#RMD1127), Vertically Integrated Medical Marijuana Treatment Center
u. Cannatech Medicinals, Inc. (#RMD1105), Vertically Integrated Medical Marijuana Treatment Center
6) Staff Recommendations on Change of Location
a. Heal, Inc., MTC Provisional License, Cultivation and Processing
b. Ipswich Pharmaceutical Associates, Inc., MTC Provisional License, Cultivation and Processing
c. Natures Remedy of Massachusetts, Inc., MTC Provisional License, Cultivation and Processing
d. Natures Remedy of Massachusetts, Inc., (#RMD1285), MTC Provisional License, Cultivation and Processing
e. Natures Remedy of Massachusetts, Inc., MTC Provisional License, Dispensing
7) Staff Recommendations on Final Licenses
a. Alternative Therapies Group, Inc. (#MR281344), Retail
b. Healthy Pharms, Inc. (#MC281631), Cultivation – Tier 4/Indoor
c. Healthy Pharms, Inc. (#MP281450), Product Manufacturing
d. Healthy Pharms, Inc. (#MR281754), Retail
e. Theory Wellness, Inc. (#MC281928), Cultivation – Tier 6/Outdoor
f. Sanctuary Medicinals, Inc., (#RMD1128) Vertically Integrated Medical Marijuana Treatment Center
8) Staff Recommendations on Provisional License Applications
a. Krypies, LLC (#MRN281594), Retail
b. Nature’s Medicines, Inc. F/K/A Xiphias Wellness (#MRN282482), Retail
c. Pure Oasis, LLC (#MRN281352), Retail
d. Silver Therapeutics, Inc. (#MPN281331), Product Manufacturing
e. The Haven Center, Inc. (#MCN282072), Cultivation – Tier 2/Indoor
f. The Haven Center, Inc. (#MPN281639), Product Manufacturing
9) Staff Recommendations on Reconsideration
a. Mass Yield Cultivation, LLC., (#MCN281392), Cultivation – Tier 2 / Indoor
10) Staff Recommendations on Change of Ownership Applications
a. Curaleaf Massachusetts, Inc.
11) Commission Discussion and Votes
a. Positive Impact Plan Guidance Update
12) New Business that the Chairman did not anticipate at time of posting
13) Next Meeting Date
Notice of Executive Session
Under the Open Meeting Law, G.L. c. 30A, § 21(a)(4) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(a), (d), (f), (g) and (n), the Commission may enter into executive session on the following agenda items:
1) to discuss provisional licensees’ qualifications for final licensure, including, but not limited to, the Commission staff’s strategies for reviewing, inspecting, and monitoring the proposed security plans of the Marijuana Establishment and for the marijuana and marijuana products.
2) to discuss operational issues, including, but not limited to, the Commission staff’s strategies for securely receiving and transferring cash deposits.
